| 9751855 |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
Waldemar Pfrengle, Thorsten Pachur, Thomas Nicola |
2017-09-05 |
| 9499546 |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
Waldemar Pfrengle, Thorsten Pachur, Thomas Nicola |
2016-11-22 |
| 8883805 |
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines |
Waldemar Pfrengle, Thorsten Pachur, Thomas Nicola |
2014-11-11 |
| 8680280 |
Process for the manufacturing of CRR inhibitors |
Rolf Schmid |
2014-03-25 |
| 8420809 |
Process for the manufacturing of betamimetics |
Thomas Krueger, Uwe Ries, Juergen Schnaubelt, Werner Rall, Zeno Andreas Leuter +1 more |
2013-04-16 |
| 8394791 |
Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug |
Ulrike Werthmann, Marco Santagostino |
2013-03-12 |
| 8372974 |
Regioselective preparation of substituted pyrimidines |
Guenter Linz, Gerd Kraemer |
2013-02-12 |
| 8334383 |
Regioselective preparation of substituted pyrimidines |
Stefan Goepper, Joerg Halmer, Michael Konrad |
2012-12-18 |
| 8207335 |
Process for making certain compounds having B1 antagonistic activity |
Markus Frank, Waldemar Pfrengle, Juergen Schnaubelt |
2012-06-26 |
| RE43115 |
Process for the manufacture of fused piperazin-2-one derivatives |
Guenter Linz |
2012-01-17 |
| 7838500 |
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
Gerd Kraemer, Hans-Juergen Martin, Gebhard Adelgoss, Klaus Dugi, Peter Eickelmann +6 more |
2010-11-23 |
| 7820815 |
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines |
Waldemar Pfrengle, Thorsten Pachur, Thomas Nicola |
2010-10-26 |
| 7626019 |
Intermediate compounds for the manufacture of fused piperazin-2-one derivatives |
Guenter Linz |
2009-12-01 |
| 7524822 |
Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
Gerd Kraemer, Hans-Juergen Martin, Gebhard Adelgoss, Klaus Dugi, Peter Eickelmann +6 more |
2009-04-28 |
| 7238807 |
Process for the manufacture of fused piperazin-2-one derivatives |
Guenter Linz |
2007-07-03 |